CovidNeuroOnc
DM Fountain,
RJ Piper,
MTC Poon,
G Solomou,
PM Brennan,
YA Chowdhury,
F Colombo,
T Elmoslemany,
FG Ewbank,
PL Grundy,
MT Hasan,
M Hilling,
PJ Hutchinson,
K Karabatsou,
AG Kolias,
NJ McSorley,
CP Millward,
I Phang,
P Plaha,
SJ Price,
O Rominiyi,
W Sage,
S Shumon,
IL Silva,
SJ Smith,
S Surash,
S Thomson,
JY Lau,
C Watts,
MD Jenkinson,
Y Al-Tamimi,
AF Alalade,
E Albanese,
M Bailey,
AR Brodbelt,
A Chalmers,
HW Chan,
DJ Coope,
S Cundliffe,
PI D'Urso,
H Entwistle,
RM Evans,
R Fielding,
C Gkolemis,
C Hammerbeck-Ward,
DS Jeyaretna,
AT King,
RM Laurente,
J Leggate,
R Lewis,
J MacLean,
C McBain,
GS McKenna,
E Molloy,
ON Pathmanaban,
P Patkar,
J Powell,
SA Rutherford,
T Santarius,
S Sinha,
M Sitaraman,
A Solth,
B Thakur,
A Wadeson,
V Wykes,
MR Zafar
Jul 02, 2021
Background
The COVID-19 pandemic has profoundly affected cancer services. Our objective was to determine the effect of the COVID-19 pandemic on decision making and the resulting outcomes for patients with newly diagnosed...